论文部分内容阅读
Tumor-initiating cells(TICs) are a subpopulation of chemoresistant tumor cells that have been shown to cause tumor recurrence.Targeting and eliminating of TICs are therefore priorities for the development of new therapeutic paradigms.Much promise lies in adoptive immunotherapy.